Cargando…
Interleukin‐22 Directly Activates Myocardial STAT3 (Signal Transducer and Activator of Transcription‐3) Signaling Pathway and Prevents Myocardial Ischemia Reperfusion Injury
BACKGROUND: Interleukin (IL)‐22, a member of the IL‐10 cytokine family, is the only known cytokine that is secreted by immune cells but does not target immune cells; it mainly targets epithelial cells. In this study, we aimed to determine whether IL‐22 administration could activate the myocardial ST...
Autores principales: | Takahashi, Jinya, Yamamoto, Mai, Yasukawa, Hideo, Nohara, Shoichiro, Nagata, Takanobu, Shimozono, Koutatsu, Yanai, Toshiyuki, Sasaki, Tomoko, Okabe, Kota, Shibata, Tatsuhiro, Mawatari, Kazutoshi, Kakuma, Tatsuyuki, Aoki, Hiroki, Fukumoto, Yoshihiro |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7428538/ https://www.ncbi.nlm.nih.gov/pubmed/32301368 http://dx.doi.org/10.1161/JAHA.119.014814 |
Ejemplares similares
-
SOCS3 deficiency in cardiomyocytes elevates sensitivity of ischemic preconditioning that synergistically ameliorates myocardial ischemia reperfusion injury
por: Nohara, Shoichiro, et al.
Publicado: (2021) -
Cardiac-Specific SOCS3 Deletion Prevents In Vivo Myocardial Ischemia Reperfusion Injury through Sustained Activation of Cardioprotective Signaling Molecules
por: Nagata, Takanobu, et al.
Publicado: (2015) -
Multidisciplinary Team-Based Palliative Care for Heart Failure and Food Intake at the End of Life
por: Shibata, Tatsuhiro, et al.
Publicado: (2021) -
Endogenous interleukin-22 prevents cardiac rupture after myocardial infarction in mice
por: Yamamoto, Mai, et al.
Publicado: (2023) -
Risk factor structure of heart failure in patients with cancer after treatment with anticancer agents’ assessment by big data from a Japanese electronic health record
por: Nohara, Shoichiro, et al.
Publicado: (2023)